Robotic Drug Patent Beats Novo Nordisk's EPO Challenge
A U.S. pharmaceutical company has beaten a challenge brought by a Danish rival to its patent for a type of robotic pill, convincing officials at the European patent office that it...To view the full article, register now.
Already a subscriber? Click here to view full article